Developmental delay (DD) or intellectual disability (ID) is a common indication of referral for genetic counselling. The identification of correct aetiology is the prerequisite for genetic counselling. In spite of complete investigations, the genetic aetiology remains unidentified in 25 to 50 per cent of cases[@ref1]. Molecular cytogenetic techniques have markedly increased the detection of chromosomal abnormalities. Traditional cytogenetics can detect the genomic imbalances more than 5 to 10 Mbp (megabase pair) size. New molecular cytogenetic techniques have led to the identification of many microdeletion/microduplication syndromes including the abnormalities of subtelomeric regions. Fluorescence *in situ* hybridization (FISH) was the first clinically used molecular cytogenetic technique[@ref2] and is still being widely used for evaluation of patients with suspected microdeletion syndrome. FISH can test one or a few regions at a time; therefore, clinical suspicion is needed before ordering the specific FISH based test[@ref3]. This limitation was overcome by multiplex ligation-dependent probe amplification (MLPA) technique[@ref4]. This technique has revolutionized the evaluation of DD/ID syndromes as it can test for 40-50 regions of the genome in a single reaction. Microarray based cytogenetic analysis is a better technique of higher resolution and simultaneous coverage of whole genome[@ref5], but high cost limits its widespread application in India.

In this study, randomly collected 203 Indian patients with ID/DD with/without malformations and dysmorphism were analyzed with MLPA technique. The utility/performance of MLPA probe sets for subtelomeric regions, common microdeletion/microduplication syndromes, and X chromosome was evaluated.

Material & Methods {#sec1-1}
==================

This study was conducted in the department of Pediatrics, Chhatrapati Shahuji Maharaj Medical University (CSMMU), Lucknow, India, during 2009 to 2011. The study protocol was approved by the institutional ethics committee of CSMMU, Lucknow.

Two hundred and three patients with DD or ID with or without malformations/dysmorphism were selected after evaluation by clinical geneticists. The blood (2 ml)samples were collected after obtaining written consent from the parents. A three generation pedigree was drawn for each case. All cases were sporadic and there was no positive family history in any of the cases. Cases in which the aetiology was detected by karyotyping, neuroimaging, metabolic screening and appropriate investigations based on clinical examination were excluded from this study. Molecular studies for fragile X syndrome were done in males without malformation or microcephaly and confirmed cases were excluded from the study. Inclusion criteria were presence of DD/ID with normal karyotype and with/without malformations or dysmorphic features. Only cases of DD/ID of unidentified aetiology were included. The average age was 5 yr (ranged from 4 months to 18 yr). There were 124 (61%) males and 79 (39%) females. The present results also include our published data on 65 cases in which only MLPA testing for subtelomeric regions was performed[@ref6]. Samples obtained from different centers for this study were as follows; Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow and CSMMU, Lucknow (130), Amrita Institute of Medical Sciences & Research Center, Cochin (50), Christian Medical College, Vellore (18), Sree Avittom Thirunal Medical college, Thiruvananthapuram (5). Assessment of intelligent quotient (IQ) was performed in cooperative children older than 6 yr of age using Malin\'s Intelligence Scale for Indian Children (an adaption of Wechsler Intelligence Scale for Children)[@ref7]. For younger children developmental quotient was assessed.

*Molecular cytogenetic methods*: Genomic DNA was isolated from peripheral blood using QIAGEN genomic DNA isolation kit (Hilden, Germany) according to manufacturer\'s instruction. MLPA was performed according to the manufacturer\'s protocol (MRC- Holland, Amsterdam). All samples were processed for MLPA with probe sets for common microdeletion syndromes as well as for subtelomeric regions. Probe sets for subtelomeric region used were P036-E1 and P070. Abnormality identified by one probe set was confirmed using another. Probe set for common microdeletion syndrome used was P245-A2. This probe set covers common syndromic regions such as Prader-Willi/Angelman, DiGeorge/Velocardiofacial, and 19 other syndromes. Deletions of 5pter, 4pter, Prader-Willi/Angelman syndrome region and Williams syndrome were confirmed by FISH analysis using probes for the respective regions. For other deletions and duplications detected by probe set P245-A2, confirmation was done by appropriate confirmatory probe sets namely; P372-A1, P373-A1, and P374-A1. Selection criteria for X-chromosome screening included males with normal MLPA profile using P245-A2 and P070/P036-E1 probe sets. Of the 124 males, 89 were screened with X-linked ID probe set (MRX, P106). Probes used in these probe sets are for the genes which are known to cause syndromes with ID/DD.

Coffalyser stand alone alpha version (coffalyser.org) was used for analysis of peak values obtained from GENESCAN software (ABI 310 instrument, Applied Biosystems, USA). Coffalyser software has built-in setup for peak height normalization and reaction quality control calculations. All the statistical analyses were performed according to coffalyser software manual instructions supplied by the manufacturer. Mean cut-off for normalized peak height ratio of patient to the control sample was less than 0.65 in case of deletions and more than 1.40 in case of duplications.

Results {#sec1-2}
=======

Two hundred and three cases were studied by both the probe sets; for subtelomeric regions and common microdeletion syndromes. Probe set P245-A2 detected 14 abnormalities with detection rate of 6.8 per cent (14/203). Abnormalities included deletions of 15q11.2, 22q11.2, 7q11.2, 1p36.33, 4p, 5p, 17p11.2 and duplication of 15q11.2 ([Table](#T1){ref-type="table"}). The presence of duplication/deletion values in 3 or 2 probes for a specific region indicates aberration. Results with MLPA confirmatory kits or FISH results were consistent with the abnormalities detected by probe set P245-A2 ([Fig. 1](#F1){ref-type="fig"}). MLPA for subtelomeric regions identified 15 duplications/deletions (7.4%, 15/203) ([Table](#T1){ref-type="table"}). The clinical features and IQ/DQ of cases with deletions/duplications are given in the [Table](#T1){ref-type="table"}. The probe sets for subtelomeric region identified abnormalities in 15 cases with deletions of 1pter, 4pter, 5pter, 9pter, 9qter, 13qter, deletion of Prader Willi/Angelman syndrome region and duplication of 9pter. This included four new cases in addition to 10 cases also detected by P245 probe set. There were 10 cases which were detected by both kits. Combining the results of subtelomeric and common microdeletion syndrome probe sets, the abnormalities were detected in 19 of the 203 cases giving the detection rate of 9.3 per cent. No deletions/duplications were found using P106 probe set for X-linked mental retardation genes. Of the 19 cases detected by MLPA probe sets, 15 were of ≤3 yr age and four were more than 3 yr. All patients with deletion/duplication had dysmorphic features ([Table](#T1){ref-type="table"}, Figs [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}).

###### 

Clinical features of patients with microdeletion/duplication syndromes and MLPA results

![](IJMR-139-66-g001)

![**(a)** & **(b)** Facial features of representative case no.2137 with 9q34.3 deletion, note flat face and prognathism. **(c & d)** MLPA P070 and P036-E1 probe sets results of case no. 2137 showing deletion of 9q34. **(e)** Facial features of case No.2877 with 4p16.33 deletion, note hypertelorism. **(f)** MLPA results of case 2877 using P373 confirmatory probe set showing deletion of 4p16.33. **(g)** FISH result of case 2275 showing single copy of 7q11.2 (pink signal). Green signals are controls (2 copies) **(h)** MLPA profile showing deletion at 7q11.29 using P245-A2 probe set **(i)** MLPA profile showing deletion at 7q11.29 using P374 confirmatory probe set.](IJMR-139-66-g002){#F1}

![**(a)** Case no. 2222- Deletion 1pter. Note straight eybrows **(b)** Case no. 2364 - Deletion 1pter. Note deep seated eyes **(c)** Case no. 2604 --Deletion 9pter **(d)** Case no. 2582- Deletion of 13qter **(e)** Case no. 2268- Deletion 15q11.2 with features though not characteristic but supportive of Angelman syndrome.](IJMR-139-66-g003){#F2}

Discussion {#sec1-3}
==========

This study identified chromosomal aetiology in 9.3 per cent cases with DD/ID of unidentified aetiology. All the cases had dysmorphism but the clinical diagnoses of specific syndromes were not made at the time of sample collection. This may be mainly because the clinical features are subtle in many cases and clinical diagnosis may become obvious as the child grows. There is a great deal of variability of clinical presentation in some of the microdeletion syndromes and clinical suspicion of a specific syndrome is difficult. In case 1887, deletion of 15q11.2 region associated with Prader-Willi/Angelman syndrome was detected by MLPA and later confirmed by FISH. This test was performed at 18 months of age and the child had DD, strabismus and microcephaly. After follow up, at 3 yr of age she had developed characteristic features of Angelman syndrome. Same was the situation with the case number 799 who was under follow up for more than a year before the clinical features of Angelman syndrome became obvious ([Fig 2e](#F2){ref-type="fig"}). The other two cases with deletion 15q11.2 had non specific dysmorphism. Case no. 2268 did not have obesity and her facial features were not characteristic but supportive of the diagnosis of Angelman syndrome. Hypotonia and joint laxity were pronounced in case number 885 supporting the diagnosis of Prader Willi syndrome. But the child did not have obesity (Body mass index of 17 kg/m^2^). The re-evaluation of clinical photographs of cases with 7q11.2 deletion revealed consistent features with the diagnosis of Williams syndrome. Both of them had prominent cheeks, thick lips but no cardiac anomaly. In these cases the clinical suspicion was possible, but was not suspected by the clinical geneticist. The syndromes of 22q 11.2 deletion, 17p11.2 deletion and terminal deletions of 1p, 4p and 5p are well delineated syndromes. Though some of the patients had clinical features consistent with the diagnosis, definitive clinical diagnosis of the particular microdeletion syndrome was not possible in many of them. Especially microduplication syndrome are difficult to suspect clinically because usually they have subtle phenotypes[@ref8]. Case number 2329 was detected to have duplication of 15q11.2 region. He had microcephaly, facial dysmorphism and undescended testes but did not have obesity, seizures and autistic features described in syndrome[@ref9].

The contribution of subtelomeric deletions and duplications to unknown ID/DD cases has long been studied by FISH and reported to be ranging from 5 to 7 per cent[@ref10][@ref11][@ref12][@ref13]. Other studies using MLPA have reported detection rates similar to those by FISH[@ref14][@ref15][@ref16]. These abberations have been classified under recurrent and non recurrent groups occuring in the human genome[@ref17]. This study identified 1pter, 4pter which are recurrent abnormalities[@ref18][@ref19][@ref20]. Phenotype of these disorders have been well delineated but clinical diagnosis is not always possible. Cases of 9pter, 9qter, 13qter deletions and duplications of 9p terminal are reported in the literatures[@ref21][@ref22][@ref23][@ref24]. Phenotype of 9pter deletion cases includes trigonocephaly and midface hypoplasia which were not present in our case[@ref25]. The features described in deletion of 9qter includes non specific features like severe mental retardation (MR), hypotonia, seizures, microcephaly and specific features like flat face, hypertelorism, synophrys, anteverted nostrils, microglossia and heart defects. The case reported in this study (case no. 2137) had flat face, synophrys, brachycepahly and prognathism. Though it may be difficult to clinically diagnose this syndrome, there is similarity of facial phenotype of this case with those reported in the literature[@ref21]. The dysmorphic features of 13qter deletion syndrome are non specific[@ref22][@ref23] as was the case in this series. Kok *et al*[@ref24] described a patient with 9p telomeric duplication with ID and short stature but no dysmorphism. The present study had 2 cases with 9pter duplication, both had different dysmorphisms. Most of cases with 9pter duplication reported are a part of complex rearrangements. Rafati *et al*[@ref26] studied 102 families with two or more individuals with ID, and showed that the prevalence of clinically significant subtelomeric rearrangements was 0.98 per cent indicating that non chromosomal causes and monogenic syndromes were more likely causes in familial ID. The present study did not have any familial case and hence, the high diagnostic yield.

Probe set P106 did not detect any abnormalities. Though X-linked genes contribute to ID in males; the deletion/duplications account for a small part of mutations in the X-linked genes[@ref27]. None of our cases had similarly affected male in the family consistent with the diagnosis of X-linked MR. This suggests that MLPA kit for X-linked MR does not have significant diagnostic yield in sporadic males with DD/ID.

In a study, MLPA was performed on 12 patients with positive FISH results, and found concordance[@ref28]. Our experience also shows consistency between both the techniques. Comparison study between MLPA subtelomeric duplications and cytogenetic microarray (CMA) technique are well documented using probe sets P070/P036-E1[@ref29]. Our experience showed concordant results with both probe sets for subtelomeric regions. As MLPA targets at multiple regions in one test, this technique is preferable to targeted FISH in clinical practice. Though the phenotypes of many microdeletion/duplication syndromes are well delineated, clinical suspicion is difficult and test targeting multiple regions or the whole genome provides high diagnostic yields. Identification of microdeletion/duplication in children with DD/ID helps these families in prevention of recurrences by providing prenatal diagnosis. Tests like MLPA and CMA which can probe multiple areas in the genome give good diagnostic yield in a complex condition like DD/ID with heterogeneous aetiologies. Detection rate of cytogenetic microarray is 15 to 20 per cent as it screens the whole genome in one go and is advocated as the first line of test in the evaluation of DD/ID. However, due to high cost of cytogenetic microarray MLPA is a good option in situations of cost constraints.
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